Janus Henderson Global Life Sciences Fund I2 HEUR
IE00B2B36G96
Janus Henderson Global Life Sciences Fund I2 HEUR/ IE00B2B36G96 /
NAV16/05/2024 |
Var.-0.0700 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
45.4600EUR |
-0.15% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Investment goal
The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
Dati master
Type of yield: |
reinvestment |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
Sector Health / Pharma |
Benchmark: |
MSCI World Healthcare Index |
Business year start: |
01/01 |
Ultima distribuzione: |
- |
Banca depositaria: |
J.P. Morgan SE, Dublin Branch |
Domicilio del fondo: |
Ireland |
Permesso di distribuzione: |
Austria, Germany, Switzerland, United Kingdom |
Gestore del fondo: |
Andy Acker, Daniel Lyons |
Volume del fondo: |
4.04 bill.
USD
|
Data di lancio: |
31/01/2008 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
2.00% |
Tassa amministrativa massima: |
1.50% |
Investimento minimo: |
1,000,000.00 EUR |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
Janus Henderson Inv. |
Indirizzo: |
201 Bishopsgate, EC2M 3AE, London |
Paese: |
United Kingdom |
Internet: |
www.janushenderson.com/
|
Attività
Stocks |
|
99.37% |
Cash |
|
0.62% |
Altri |
|
0.01% |
Paesi
United States of America |
|
72.74% |
Denmark |
|
6.56% |
United Kingdom |
|
4.02% |
Switzerland |
|
3.34% |
France |
|
2.48% |
Ireland |
|
2.39% |
Netherlands |
|
1.60% |
Japan |
|
1.56% |
Virgin Islands (British) |
|
1.15% |
China |
|
0.72% |
Cash |
|
0.62% |
Cayman Islands |
|
0.30% |
Canada |
|
0.21% |
Altri |
|
2.31% |
Filiali
Pharma/Biotechnology |
|
61.27% |
Healthcare appliances |
|
17.19% |
Healthcare services |
|
16.98% |
Parma, wholesale |
|
1.63% |
Cash |
|
0.62% |
Altri |
|
2.31% |